{"nctId":"NCT00882440","briefTitle":"A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)","startDateStruct":{"date":"1990-12"},"conditions":["Hypertension"],"count":576,"armGroups":[{"label":"1","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: losartan potassium"]},{"label":"3","type":"EXPERIMENTAL","interventionNames":["Drug: losartan potassium"]},{"label":"4","type":"EXPERIMENTAL","interventionNames":["Drug: losartan potassium"]},{"label":"5","type":"EXPERIMENTAL","interventionNames":["Drug: losartan potassium"]},{"label":"6","type":"EXPERIMENTAL","interventionNames":["Drug: losartan potassium"]},{"label":"7","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Enalapril"]}],"interventions":[{"name":"losartan potassium","otherNames":["MK0954","Cozaar"]},{"name":"Placebo","otherNames":[]},{"name":"Enalapril","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient has been diagnosed with mild to moderate hypertension, with supine diastolic blood pressure of 100 to 115 mmHg\n* Patient has no active medical problems other than essential hypertension that might affect blood pressure\n* Patient has received no drug therapy that might affect blood pressure\n\nExclusion Criteria:\n\n* Prior exposure to losartan\n* History of stroke\n* History of myocardial infarction\n* Atrial flutter or atrial fibrillation\n* History of congestive Heart failure\n* Known Sensitivity to ACE inhibitors\n* Known positive test for HIV/AIDS or Hepatitis B\n* Patient is being treated for acute ulcer disease\n* History of chronic liver disease\n* Actively treated diabetes mellitis\n* Any known bleeding or platelet disorder\n* Absence of one kidney\n* Women of childbearing potential or who are breastfeeding\n* Patient is abusing or has a history of alcoholism or drug addiction","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"SECONDARY","title":"Categories of Antihypertensive Response in Trough Supine Diastolic Blood Pressure (SuDBP) at Week 8","description":"Patients in Category I (defined as \"excellent\" in protocol) if SuDBP was \\<90 mmHg, Category II (defined as \"good\" in protocol) if SuDBP was ≥90 but decreased at least 10 mmHg, or Category III (defined as \"fair\" or \"inadequate\" in protocol) if SuDBP was ≥90 and decreased less than 10 mmHg.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"19","spread":null},{"groupId":"OG002","value":"21","spread":null},{"groupId":"OG003","value":"24","spread":null},{"groupId":"OG004","value":"29","spread":null},{"groupId":"OG005","value":"28","spread":null},{"groupId":"OG006","value":"35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"17","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"15","spread":null},{"groupId":"OG004","value":"19","spread":null},{"groupId":"OG005","value":"12","spread":null},{"groupId":"OG006","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null},{"groupId":"OG001","value":"44","spread":null},{"groupId":"OG002","value":"54","spread":null},{"groupId":"OG003","value":"39","spread":null},{"groupId":"OG004","value":"41","spread":null},{"groupId":"OG005","value":"44","spread":null},{"groupId":"OG006","value":"31","spread":null}]}]}]},{"type":"PRIMARY","title":"Mean Change From Baseline in Trough Supine Diastolic Blood Pressure (SuDBP) at Week 8","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.6","spread":"7.8"},{"groupId":"OG001","value":"-7.9","spread":"7.6"},{"groupId":"OG002","value":"-6.8","spread":"7.9"},{"groupId":"OG003","value":"-10.1","spread":"7.0"},{"groupId":"OG004","value":"-9.9","spread":"6.9"},{"groupId":"OG005","value":"-9.7","spread":"8.0"},{"groupId":"OG006","value":"-11.2","spread":"6.7"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Peak Supine Diastolic Blood Pressure (SuDBP) at Week 8","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.7","spread":"8.7"},{"groupId":"OG001","value":"-7.3","spread":"9.4"},{"groupId":"OG002","value":"-9.9","spread":"8.5"},{"groupId":"OG003","value":"-11.9","spread":"9.2"},{"groupId":"OG004","value":"-10.4","spread":"8.9"},{"groupId":"OG005","value":"-13.1","spread":"9.0"},{"groupId":"OG006","value":"-16.2","spread":"10.4"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}}